Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Icu Medical (ICUI) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Icu Medical (ICUI) over the last 17 years, with Q1 2025 value amounting to $8.4 million.

  • Icu Medical's Gains from Investment Securities fell 2631.58% to $8.4 million in Q1 2025 from the same period last year, while for Sep 2025 it was $27.4 million, marking a year-over-year increase of 77748.96%. This contributed to the annual value of -$5.4 million for FY2024, which is 6676.92% up from last year.
  • As of Q1 2025, Icu Medical's Gains from Investment Securities stood at $8.4 million, which was down 2631.58% from $19.0 million recorded in Q4 2024.
  • Icu Medical's Gains from Investment Securities' 5-year high stood at $19.0 million during Q4 2024, with a 5-year trough of -$27.2 million in Q2 2022.
  • Its 5-year average for Gains from Investment Securities is $460800.0, with a median of -$339000.0 in 2024.
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first tumbled by 37625.3% in 2023, then skyrocketed by 57617.14% in 2024.
  • Icu Medical's Gains from Investment Securities (Quarter) stood at -$4.9 million in 2021, then surged by 82.75% to -$838000.0 in 2022, then tumbled by 376.25% to -$4.0 million in 2023, then soared by 576.17% to $19.0 million in 2024, then crashed by 55.8% to $8.4 million in 2025.
  • Its Gains from Investment Securities was $8.4 million in Q1 2025, compared to $19.0 million in Q4 2024 and -$3.9 million in Q3 2024.